Organization · Venture Capital
UTokyo Innovation Platform Co., Ltd.
UTokyo Innovation Platform Co., Ltd. is a venture investment company based in Tokyo, Japan, focused on fostering an innovation ecosystem by supporting startups derived from academia. It primarily invests in deep tech sectors addressing societal challenges.
Overview
What UTokyo Innovation Platform Co., Ltd. does
What UTokyo Innovation Platform Co., Ltd. is
UTokyo Innovation Platform Co., Ltd. is a venture investment company based in Tokyo, Japan, focused on fostering an innovation ecosystem by supporting startups derived from academia. It primarily invests in deep tech sectors addressing societal challenges.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 30, 2026
Official channels
Find UTokyo Innovation Platform Co., Ltd. elsewhere
Open the official website or a supported primary organization account.
Capability profile
UTokyo Innovation Platform Co., Ltd. as a funder
Investment thesis
UTokyo Innovation Platform Co., Ltd. aims to foster an innovation ecosystem by commercializing research outputs from the University of Tokyo and supporting the growth of startups derived from academia.
Focus narrative
UTokyo IPC primarily invests in deep tech startups across various sectors, including life sciences, agritech, space, hardware, IT and services, and artificial intelligence. The organization operates three funds, managing nearly 60 billion yen, and provides extensive support services such as incubation and partnerships with stakeholders.
Value beyond capital
UTokyo IPC adds value to its portfolio companies through hands-on assistance, incubation services, and strategic partnerships with various stakeholders, leveraging its strong ties to the University of Tokyo and its research capabilities.
Terms and economics
- Typical check
- $100,000–$5,000,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Growth Equity
- Sectors
- Biotech & Life SciencesHealthcareAgTechSpace TechRobotics & Autonomous SystemsArtificial Intelligence
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 80
- Recorded notable exits
- Akiurna, Modalis, Adriacaim, and Heartseed
Portfolio context
UTokyo IPC has invested in notable companies such as Kryut Medical Systems, which developed the world's first head-mounted automatic visual field testing device; Akiurna, focused on drug delivery systems for nucleic acid medicines; TagSix Bio, engaged in drug discovery using artificial DNA base pairs; and Brayzon Therapeutics, known for its innovative drug delivery system that crosses the blood-brain barrier. Other portfolio companies include Modalis, Arivexis, Adriacaim, and Heartseed, which focus on various advanced technologies in healthcare and beyond.
Capability profile
UTokyo Innovation Platform Co., Ltd. as a program host
Program thesis
UTokyo Innovation Platform Co., Ltd. aims to foster an innovation ecosystem by supporting the creation and growth of startups derived from academia, focusing on returning knowledge from research institutions to society and generating new industries and value.
Focus narrative
UTokyo IPC primarily invests in deep tech startups that tackle significant societal challenges. The organization operates three funds, managing nearly 60 billion yen, and offers a variety of support services, including incubation, hands-on assistance, and partnerships with various stakeholders. Key sectors of interest include Life Sciences, Agritech, Space, Hardware, IT and Services, and Artificial Intelligence.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
Alumni and track record
Alumni context
Notable alumni companies include Kryut Medical Systems, which developed the world's first head-mounted automatic visual field testing device; Akiurna, focused on drug delivery systems for nucleic acid medicines; TagSix Bio, engaged in drug discovery using artificial DNA base pairs; Brayzon Therapeutics, known for a groundbreaking drug delivery system that crosses the blood-brain barrier; and Modalis, recognized for its unique genome editing platform for drug discovery.
Common questions
What to know about UTokyo Innovation Platform Co., Ltd.
Upseed classifies UTokyo Innovation Platform Co., Ltd. under the Venture Capital organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.